Adherence to Otezla

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

February 28, 2026

Conditions
Psoriasis
Interventions
DRUG

Otezla - Standard Care

The participant will be given their medication with the electronic adapter cap on it and asked to return for the follow-up visit

BEHAVIORAL

Reminder Text Intervention with apremilast

Participants will receive a weekly electronic text/email-based intervention that is designed to promote better adherence to treatment in addition to receiving their medication with the electronic adapter cap on it.

BEHAVIORAL

Extended Consultation for apremilast

Participants will be given their medication with the electronic adapter cap on it and will receive an initial patient consult intervention, which will focus on medication education and setting expectations of what to anticipate with usage of the prescribed medication

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER